Kevzara — Medical Mutual

Initial criteria

• Kevzara is prescribed by or in consultation with a rheumatologist
• Patient has tried and/or failed ONE systemic corticosteroid OR patient is not a candidate for corticosteroid therapy

Reauthorization criteria

• Patient has had a response (e.g., less joint pain, morning stiffness, or fatigue; improved function or activities of daily living; decreased soft tissue swelling in joints or tendon sheaths; improved laboratory values; reduced corticosteroid dosage), as determined by the prescriber

Approval duration

initial 6 months, reauth 1 year